Praluent Drug Interactions: What to Avoid and What to Tell Your Doctor

One of the major advantages of Praluent (alirocumab) over many cholesterol medications is its low drug interaction profile. Because it's a biologic monoclonal antibody — not a small molecule processed by liver enzymes — it avoids most of the CYP450-mediated drug-drug interactions that create problems with statins and other oral drugs. But "few interactions" doesn't mean "no concerns." Here's what you and your doctor need to know.

Why Praluent Has Very Few Drug Interactions

Praluent is a large protein molecule (a monoclonal antibody). When your body processes it, Praluent is degraded into small peptides and individual amino acids — the same way any dietary protein is broken down. It is not metabolized by the cytochrome P450 (CYP450) enzyme system in the liver, which is responsible for metabolizing most common drugs.

This means Praluent does not:

Inhibit or induce CYP enzymes (CYP3A4, CYP2D6, etc.)

Compete with other drugs for liver metabolism pathways

Significantly affect the blood levels of statins or other co-administered medications

Clinical studies confirmed this: when Praluent was administered in combination with atorvastatin or rosuvastatin, no meaningful changes in statin concentrations were observed. Praluent is listed as having no severe, serious, or moderate drug-drug interactions in major interaction databases.

Is It Safe to Take Praluent with Statins?

Yes — and in fact, most patients take Praluent alongside statin therapy. The two drugs have complementary mechanisms:

Statins reduce cholesterol synthesis in the liver

Praluent increases LDL receptor activity by blocking PCSK9

Together, they typically achieve greater LDL-C reduction than either drug alone. The ODYSSEY OUTCOMES trial enrolled over 18,000 patients on maximally tolerated statin therapy alongside Praluent — validating this combination as both safe and effective.

Can Praluent Be Used with Ezetimibe?

Yes. Praluent can be combined with ezetimibe (Zetia) and statins — a triple-drug regimen sometimes used for patients with very high LDL-C who haven't reached goal on a statin plus ezetimibe alone. No clinically significant interaction between alirocumab and ezetimibe has been identified.

Can Praluent Be Used with Leqvio (Inclisiran)?

No — not in the same regimen. Some insurance prior authorization policies specifically state that Praluent is not to be used in combination with Leqvio (inclisiran). Both drugs target the PCSK9 pathway (though through different mechanisms), and combining two PCSK9-targeting drugs would be redundant rather than additive and hasn't been studied for safety or benefit.

39,483+ patients found their medications in stock

39K+

Find Praluent In Stock Today →

Medications That May Be Affected Near Praluent Initiation

While Praluent itself has no known significant interactions with other drugs, there's an indirect consideration: Praluent dramatically lowers LDL-C, which affects some lab values and may require medication adjustments in rare circumstances. For example, very low LDL-C levels may affect the interpretation of lipid panels used to adjust other cardiovascular medications.

Also note: Praluent causes a measurable reduction in LDL-C within 2 weeks. If you have your cholesterol checked soon after starting Praluent, make sure your healthcare provider knows when you started the medication so they can interpret results correctly.

What to Tell Your Doctor Before Starting Praluent

Even with Praluent's low interaction profile, always give your healthcare provider and pharmacist a complete medication list before starting. Include:

All prescription medications (including all cholesterol medications, blood pressure drugs, anticoagulants like warfarin or apixaban, diabetes medications)

Over-the-counter medications (especially NSAIDS, aspirin, antacids)

Vitamins and supplements (including fish oil, CoQ10, niacin, red yeast rice)

Herbal products

Any history of allergic reactions to biologics or injectable medications

Skip the calls, skip the stress.

Find Praluent In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Special Populations: Pregnancy, Breastfeeding, and Older Adults

Pregnancy: Safety is unknown. Monoclonal antibodies cross the placenta, particularly in the third trimester. Report pregnancy to Regeneron at 1-844-734-6643. Avoid Praluent unless benefit clearly outweighs risk.

Breastfeeding: Unknown whether alirocumab passes into breast milk in significant amounts. Discuss with your doctor before using while breastfeeding.

Older adults: No dose adjustment is needed for older patients. Age, body weight, gender, and race were not found to significantly affect Praluent's pharmacokinetics.

Kidney or liver disease: No dose adjustment for mild-to-moderate impairment. No data available for severe renal or hepatic impairment — use with caution and provider guidance.

For a complete guide to Praluent side effects, including how to manage injection site reactions and warning signs of allergic reactions, see our article on Praluent side effects.

If you've been prescribed Praluent and need help locating it, medfinder calls pharmacies near you to find which ones have it in stock.